Combination of reovirus (pelareorep) and granulocyte-macrophage colony-stimulating factor (GM-CSF) alongside standard chemoradiotherapy and adjuvant chemotherapy (temozolomide) for patients with glioblastoma multiforme (GBM): Long term follow up results of the ReoGlio phase Ib trial
Short, S. C. Kendall, J. Chalmers, A. McBain, Catherine A Melcher, A. Samson, A. Phillip, R. Brown, S.
Short, S. C.
Kendall, J.
Chalmers, A.
McBain, Catherine A
Melcher, A.
Samson, A.
Phillip, R.
Brown, S.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Short SC, Kendall J, Chalmers A, McBain C, Melcher A, Samson A, et al. Combination of reovirus (pelareorep) and granulocyte-macrophage colony-stimulating factor (GM-CSF) alongside standard chemoradiotherapy and adjuvant chemotherapy (temozolomide) for patients with glioblastoma multiforme (GBM): Long term follow up results of the ReoGlio phase Ib trial. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509500043.